Abstract

The present study was designed to ascertain sequentially the pressor response to angiotensin II in young primigravid patients throughout pregnancy in order a) to define when in pregnancy resistance to the pressor effects of angiotensin II develops; b) to define the physiologic sequence of events leading to this resistance; and c) to ascertain whether sensitivity to infused angiotensin II could be detected before the onset of clinical signs of pregnancy-induced hypertension.

Authors

Norman F. Gant, Gilroy L. Daley, Santosh Chand, Peggy J. Whalley, Paul C. MacDonald

×

Other pages: